Identified 30-60% EBITDA growth opportunities at a target multinational healthcare business

Business challenge

Our client wanted to assess both EBITDA potential in the existing business, and the potential in further international expansion

Context

The target had multiple patient touchpoints but limited business integration within country, and little cross‑country sharing of knowledge or back‑office services

Business impact

• ~60%of EBITDA opportunity on revenue by increasing in‑system referrals and improving corporate managed care offering
• ~40%of EBITDA opportunity on costside through optimising in‑clinic support to maximise doctor productivity and automating/ centralising back office

Top line solution

• Interviewed management and experts in each country
• Mystery shopped services the target and their competitors
• Assessed uplift potential in existing businesses against internal andexternal benchmarks
• Analysed and prioritised international growth options across 11 target countries

Key takeaway

• Integrating services can generate outsize returns, justifying the effort
• Bottlenecks exist in every process –focus on the high‑value ones first (here administration overhead for doctors)